Nissan Medical Industries Ltd.

Nissan Medical Industries Ltd.

TTASE:NISA
940.10
ILA
+10.00
(+1.08%)
158.46EPS
9.60P/E
7.00BMarket Cap
Nissan Medical Industries Ltd.
TASE:NISA
(Tel Aviv Stock Exchange)

Recent

price

940.10

P/E

ratio

9.60

div

yld

- -

ROIC.AI

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
ILS
51.39
56.39
58.34
56.09
64.33
72.48
66.65
79.42
73.58
75.37
80.79
73.1
71.75
67.08
Revenue per Share
5.14
0.07
4.09
1.97
1.4
2.76
1.73
6.26
3.96
-3.97
0.62
0.87
0.46
0.8
Basic EPS, GAAP
6.85
7.1
11.08
-1.8
4.16
8.13
4.93
11.96
1.07
0.22
10.52
2.26
4.02
3.49
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
1.1
1
0.44
- -
0.75
1.82
- -
Dividend per Share
- -
10.07
14.01
14.84
14.91
18.92
18.96
23.05
25.09
23.71
25.18
25.35
21.32
20.47
Book Value per Share
- -
3.41
7.38
8.21
8.29
12.33
12.39
16.5
18.54
19.74
21.18
21.36
17.37
16.52
Tangible Book Value per Share
9
9
9
9
9
9
9
9
9
9
9
9
9
9
Basic Weighted Avg Shares
467
512
530
509
584
658
605
721
668
685
734
664
652
607
Sales/Revenue/Turnover
12.8
13.04
17.96
9.48
4.72
9.21
6.07
15.29
9.86
-0.28
8.53
4.47
3.34
4.59
Operating Margin (%)
16
17
18
25
26
26
29
27
26
29
31
30
28
26
Depreciation Expense
47
1
37
18
13
25
16
57
36
-36
6
8
4
7
Net Income, GAAP
22.25
44.59
23.55
18.78
- -
20.06
17.27
15.56
18.87
- -
31.56
8.92
13.25
14.18
Effective Tax Rate (%)
10
0.12
7.01
3.52
2.17
3.81
2.59
7.88
5.39
-5.27
0.77
1.19
0.64
1.2
Profit Margin (%)
- -
-14
-26
-54
-83
-95
-96
1
64
38
35
27
-1
-4
Working Capital
- -
169
302
272
201
152
115
128
143
132
77
52
46
46
LT Debt
- -
152
199
220
222
272
274
324
344
332
355
355
307
295
Total Equity
- -
- -
14.55
6.31
- -
8.41
4.95
16.08
9.17
- -
7.52
4.94
3.14
4.08
Return on Invested Capital (%)
- -
- -
2.57
2.33
- -
3.47
2.87
5.08
3.61
- -
1.2
2.55
1.91
1.66
Return on Capital (%)
- -
- -
33.95
13.67
9.41
16.34
9.13
29.79
16.47
-16.26
2.54
3.45
1.97
3.6
Return on Common Equity (%)

Capital Structure

ILS

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
144
142
133
LT Borrowings
35
34
35
LT Finance Leases
12
12
11
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
9
9
9
Market Capitalization
83
80
70

Working Capital

ILS

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
218
216
217
Cash, Cash Equivalents & STI
18
13
14
Accounts Receivable, Net
76
89
71
Inventories
114
105
114
Total Current Liabilities
219
227
221
Payables & Accruals
- -
- -
- -
ST Debt
144
142
133
Deferred Revenue
- -
- -
- -

Growth Rates

ILS

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-13.43%
Free Cash Flow
430.27%
910.24%
77.79%
Net Income, GAAP
-11.85%
-71.94%
-47.22%
Sales/Revenue/Turnover
2.55%
-1.82%
-1.85%
Total Cash Common Dividend
- -
- -
142.65%

Quarterly Revenue

ILS

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
193
168
167
137
664
2025
158
166
180
148
652
2026
146
134
- -
- -
- -

Quarterly Earnings Per Share

ILS

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.98
0.28
- -
-0.41
0.87
2025
-0.22
0.35
0.3
0.05
0.46
2026
-0.26
0.71
- -
- -
- -

Quarterly Dividends Per Share

ILS

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.75
2025
- -
- -
- -
- -
1.82
2026
- -
- -
- -
- -
- -
Business
Nissan Medical Industries Ltd Nissan Medical Industries Ltd (NISA.TA) is an Israel-based company that engages in the production of surgical dressing products and the manufacturing and marketing of gauze and non-woven fabrics, primarily using spunlace water entanglement technology. The company offers a comprehensive range of core products including gauze and non-woven swabs, absorbent pads, absorbent balls, laparotomy sponges, bandages, kits, double peel-packs, and orthopedic padding; these are supplied to medical centers, pharmacies, defense forces, and private hospitals in Israel and abroad, with operations extending to the United States and Canada through subsidiaries. Founded in January 1984 by Yeheskel Nissan and headquartered at 11 Harugei Malkhut Street in Tel Aviv, Israel, the company operates in the medical equipment, supplies, and distribution sector, serving healthcare and hygienic applications. In recent developments, Nissan Medical Industries Ltd reported a net loss of ₪0.22 per share for the first quarter of 2025, reflecting an 18% revenue decline to ₪157.9 million amid operational challenges. The company maintains a workforce of approximately 406 employees and continues to focus on its core non-woven fabric production without notable acquisitions, partnerships, funding rounds, or major strategic shifts announced in the last 1-2 years. Its shares trade on the Tel Aviv Stock Exchange with a recent market capitalization of around 93.47 million ILS and a high dividend yield exceeding 19%.